Date: 7/8/2010
When a patient receives a heart stent, the interventional cardiologist prescribes antiplatelet therapy - a combination of medicines that work together to prevent stent thrombosis, or the formation of blood clots in or around the stent that can block blood flow, possibly resulting in a heart attack or even death. Antiplatelet therapy usually consists of (1) aspirin and (2) either Plavix® (clopidogrel) or Effient® (prasugrel).
Date: 5/26/2010
Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST), published in The New England Journal of Medicine this week, found carotid artery stenting (CAS) is equally safe and as effective as carotid endarterectomy (CEA) for stroke prevention.
Date: 5/23/2010
The Society for Cardiovascular Angiography and Interventions (SCAI) was awarded the 10th Annual Wenger Award for excellence in health care for the Society's dedication to raising awareness about disparities in heart health care. Awarded annually by WomenHeart: The National Coalition for Women with Heart Disease, the Wenger award seeks to honor individuals and organizations for their commitment to improving the lives of women with heart disease.
Date: 5/10/2010
Progress in the fight against heart disease has been at times slow, but remarkably steady and effective. Over the years, however, coronary heart disease has remained the #1 killer in the United States, surpassing all cancer-related deaths.
Date: 5/7/2010
Patients treated with the Zilver® PTXTM Drug-Eluting Peripheral Stent maintained clinical improvement at two years, according to interim results from the Zilver® PTXTM Global Registry presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd Annual Scientific Sessions.